Sign in
4/A

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-016097

Director acquired 2,011 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2023-11-16 Other acquisition 10b5-1 +66 $1.73 $114 227,925 D
Krogulski Kenneth Director 2023-11-17 Other acquisition 10b5-1 +280 $1.83 $512 228,205 D
Krogulski Kenneth Director 2023-11-20 Other acquisition 10b5-1 +268 $1.70 $456 228,473 D
Krogulski Kenneth Director 2023-11-21 Other acquisition 10b5-1 +125 $1.76 $220 228,598 D
Krogulski Kenneth Director 2023-11-22 Other acquisition 10b5-1 +280 $1.74 $487 228,878 D
Krogulski Kenneth Director 2023-11-27 Other acquisition 10b5-1 +379 $1.86 $705 229,257 D
Krogulski Kenneth Director 2023-11-28 Other acquisition 10b5-1 +124 $1.68 $208 229,381 D
Krogulski Kenneth Director 2023-11-29 Other acquisition 10b5-1 +165 $1.73 $285 229,546 D
Krogulski Kenneth Director 2023-11-30 Other acquisition 10b5-1 +324 $1.66 $538 229,870 D
Loading xslF345X05/marketforms-63722.xml…